Search results for "ARTERIAL"

showing 10 items of 714 documents

Palpación de pulsos arteriales en el miembro inferior

2010

Los pulsos periféricos del miembro inferior que sistemáticamente se valoran son: el pulso femoral, el pulso pedio, el pulso tibial posterior y el pulso popliteo.

3213.11 Ciències MédiquesFisioterapiaexploración clínicaarteriopatía periféricapalpaciópulso arterialFisioterapia3213.11- Farmacia Medicina
researchProduct

Palpación de pulsos arteriales de cara y cuello

2010

Los pulsos periféricos de cuello y cara que sistemáticamente se valoran son: el pulso carotídeo, el pulso temporal y el pulso facial.

3213.11 Ciències MédiquesFisioterapiaexploración clínicaarteriopatía periféricapalpaciópulso arterialFisioterapia3213.11- Farmacia Medicina
researchProduct

Exposición pre y postnatal a mercurio y presión arterial en preescolares

2019

Antecedentes y objetivos Según la Organización Mundial de la Salud, el mercurio es uno de los diez principales productos químicos o grupos de productos que son motivo de preocupación para la salud pública. La presión arterial sistólica elevada es el principal factor de riesgo de enfermedad y muerte por cualquier causa, y es modificable. La investigación en modelos animales ha encontrado elevaciones en la presión arterial sistólica tras exposiciones a metilmercurio, la forma química del mercurio más tóxica. En población adulta se ha encontrado una relación dosis-respuesta entre la exposición postnatal a mercurio y el riesgo de hipertensión arterial, no lineal, con un cambio de tendencia alre…

:CIENCIAS MÉDICAS ::Patología::Patología cardiovascular [UNESCO]:QUÍMICA::Química orgánica ::Compuestos organometálicos [UNESCO]UNESCO::CIENCIAS MÉDICAS ::Patología::Patología cardiovascularmetilmercurioUNESCO::QUÍMICA::Química orgánica ::Compuestos organometálicosmercuriopresión arterial:CIENCIAS MÉDICAS ::Epidemiología [UNESCO]UNESCO::CIENCIAS MÉDICAS ::Ciencias clínicas::Pediatríasalud públicapediatría:CIENCIAS MÉDICAS ::Ciencias clínicas::Pediatría [UNESCO]UNESCO::CIENCIAS MÉDICAS ::Epidemiologíahipertensiónpatología cardiovascularepidemiología
researchProduct

Cambios en la expresión de adrenoceptores y GRK en insuficiencia cardiaca e hipertensión arterial

2015

En la insuficiencia cardiaca humana, se ha observado una disminución en la expresión de los adrenoceptores β1 (AR-β1) junto con un aumento de la expresión/función de la cinasa GRK2, pero los cambios en la expresión de otros AR y GRK no han sido establecidos. Otra cuestión sin resolver es la incidencia de estos mecanismos en función de la etiología y el tratamiento de la insuficiencia cardíaca. Queda también por determinar la existencia de un patrón transcripcional común que regula los niveles de ARNm de cada isoforma de GRK y los subtipos de AR-β. Para analizar estas cuestiones, hemos cuantificado la expresión de ARNm y proteína de seis AR (α1A, α1B, α1D, β1, β2 y β3) y tres GRKs (GRK2, GRK…

:CIENCIAS MÉDICAS ::Patología::Patología cardiovascular [UNESCO]Biología molecularUNESCO::CIENCIAS DE LA VIDA::Biología molecularUNESCO::CIENCIAS MÉDICAS ::Patología::Patología cardiovascular:CIENCIAS MÉDICAS ::Farmacología [UNESCO]CardiovascularUNESCO::CIENCIAS MÉDICAS ::Farmacología:CIENCIAS DE LA VIDA [UNESCO]:CIENCIAS DE LA VIDA::Biología molecular [UNESCO]Hipertensión arterialAdrenoreceptoresUNESCO::CIENCIAS DE LA VIDAInsuficiencia cardiaca
researchProduct

Standalone sauna vs exercise followed by sauna on cardiovascular function in non‐naïve sauna users: A comparison of acute effects

2021

Background and aimsSauna bathing and aerobic exercise have each been shown to affect cardiovascular function. However, direct comparisons between standalone sauna bathing and a combination of exercise and sauna on vascular indices remain limited. Therefore, we conducted a cross-over study using matched durations to explore the hemodynamic changes of sauna exposure when compared to a combination of aerobic exercise and sauna exposure.MethodsParticipants (N = 72) with at least one cardiovascular risk factor underwent, on two separate occasions: (a) a 30-minute sauna at 75°C (SAUNA) and (b) the combination of a 15-minute cycling exercise at 75% maximum heart rate followed by 15-minute sauna ex…

Acute effectsmedicine.medical_specialtyMean arterial pressurehypertensionsaunominenHemodynamicsvaltimotInternal medicinenon‐pharmocological therapyHeart ratekohonnut verenpainemedicineAerobic exerciseRisk factorResearch ArticlesAerobic exercisebusiness.industryRGeneral Medicineaerobinen harjoittelumedicine.diseaseverenpaineaerobic exerciseBlood pressureCardiologyArterial stiffnessMedicinelifestyle modificationnon-pharmocological therapybusinessarterial compliancefysiologiset vaikutuksetResearch ArticleHealth Science Reports
researchProduct

Changes in Perfusion Pattern of Experimental Tumors Due to Reduction in Arterial Oxygen Partial Pressure

2006

Acute hypoxiamedicine.medical_treatmentAnesthesiamedicineTumor OxygenationChronic hypoxiaPerfusionReduction (orthopedic surgery)Arterial oxygen partial pressure
researchProduct

Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER…

2021

Abstract Aims In this secondary analysis of the VOYAGER trial, rivaroxaban 2.5 mg twice/day plus aspirin 100 mg/day was assessed in older adults. Advanced age is associated with elevated bleeding risk and unfavourable net benefit for dual antiplatelet therapy in chronic coronary artery disease. The risk–benefit of low-dose rivaroxaban in patients ≥75 years with peripheral artery disease (PAD) after lower extremity revascularization (LER) has not been described. Methods and results The primary endpoint was a composite of acute limb ischaemia, major amputation, myocardial infarction, ischaemic stroke, or cardiovascular death. The principal safety outcome was thrombolysis in myocardial infarct…

Acute limb ischaemiamedicine.medical_specialtyBrain IschemiaPeripheral Arterial DiseaseRivaroxabanInternal medicineClinical endpointHumansMedicineMyocardial infarctionAgedRivaroxabanAspirinbusiness.industryAbsolute risk reductionNumber needed to harmmedicine.diseaseStrokeCardiologyNumber needed to treatDrug Therapy CombinationCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation InhibitorsTIMIFactor Xa Inhibitorsmedicine.drugEuropean Heart Journal
researchProduct

Insufficienza renale acuta in paziente con carcinoma epatocellulare sottoposto a chemioembolizzazione transarteriosa

2007

Transarterial chemoembolization (TACE) is included among the wide therapeutic tools for the treatment of hepatocellular carcinoma (HCC), tumour with high frequency and malignancy. The approach is invasive and, beyond the discomfort for the patient, it is charged by a number of side effects and complications. In this study we report the case of renal acute failure of hypovolemic origin, as a consequence of a TACE in a patient suffering from HCC, occurred after one week of intervention. The different possible mechanisms involved in the pathogenesis of this complication are discussed.

Acute renal failureHepatocellular carcinomaMedicine (all)Trans-arterial chemioembolization
researchProduct

Arterial Embolism to the Upper Extremity in a Patient with Factor V Leiden Mutation (APC Resistance)

2003

Factor V Leiden mutation has emerged as one of the leading abnormalities in inherited blood coagulation disorders, resulting in a markedly increased risk for deep leg vein thrombosis. A 24- year-old woman presented with acute onset of critical ischemia of her left thumb and index finger. Intraarterial angiography revealed an embolus in the distal radial artery and a thrombotic occlusion of the digital artery of the thumb and index finger. Immediate therapy encompassed a selective surgical embolectomy of the distal radial artery followed by a local intraarterial lysis that was continued for 3 days. Additionally, therapeutic anticoagulation and vasodilating drugs (prostaglandin E) were admin…

Adult0301 basic medicinemedicine.medical_specialtyArterial embolismmedicine.medical_treatmentEmbolectomy030204 cardiovascular system & hematologyFingers03 medical and health sciences0302 clinical medicineEmbolusIschemiaThromboembolismmedicine.arterymedicineFactor V LeidenHumansRadial arteryActivated Protein C Resistancemedicine.diagnostic_testbiologybusiness.industryFactor Vmedicine.diseaseCapillary refillSurgeryRadiographybody regions030104 developmental biologyThumbEmbolismRadial Arterybiology.proteinFemaleCardiology and Cardiovascular MedicinebusinessAngiology
researchProduct

Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma

2017

Abstract Background Transarterial chemoembolisation is the standard of care for intermediate stage (BCLC B) hepatocellular carcinoma, but it is challenging to decide when to repeat or stop treatment. Here we performed the first external validation of the SNACOR (tumour Size and Number, baseline Alpha-fetoprotein, Child-Pugh and Objective radiological Response) risk prediction model. Methods A total of 1030 patients with hepatocellular carcinoma underwent transarterial chemoembolisation at our tertiary referral centre from January 2000 to December 2016. We determined the following variables that were needed to calculate the SNACOR at baseline: tumour size and number, alpha-fetoprotein level,…

AdultAged 80 and overMaleCarcinoma HepatocellularHepatocellular carcinomaLiver Neoplasms610 MedizinKaplan-Meier EstimateSNACORMiddle Agedlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282Magnetic Resonance ImagingTreatment OutcomeTransarterial chemoembolisation610 Medical sciencesBiomarkers TumorHumansFemaleChemoembolization TherapeuticTomography X-Ray ComputedAgedNeoplasm StagingResearch Article
researchProduct